Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)
Close on Nov 17, 2026Market cap $37.82MP/E –Yield –
Elutia pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Elutia's pe ratio was 0.8× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | – |
See a number that looks wrong?